Themba Ngobeni | Innovative Leadership | Innovative Research Award

Innovative Research Award

Themba Ngobeni
Cape Peninsula University of Technology

Themba Ngobeni
Affiliation Cape Peninsula University of Technology
Country South Africa
Scopus ID 57219287291
Documents 3
Citations 2
h-index 1
Subject Area Innovative Leadership
Event Leadership Global Awards
ORCID 0000-0002-2216-1943

The Innovative Research Award article summarizes the publicly available scholarly profile and research-related indicators associated with Themba Ngobeni of the Cape Peninsula University of Technology. The page presents an encyclopedic overview of institutional affiliation, publication activity, citation metrics, research contributions, and the relationship of these indicators to recognition within the Leadership Global Awards. The presentation follows a neutral academic style and should be interpreted as an informational profile rather than an independent assessment of eligibility or merit.[1][2]

Abstract

This article provides a structured academic overview of Themba Ngobeni’s publicly reported scholarly record, including affiliation, indexed publications, citation indicators, and research visibility. The information is organized in a format comparable to an academic reference entry and is intended to support readers seeking a concise summary of research activity and professional recognition within the context of innovative leadership scholarship.[1][3]

Keywords

Innovative leadership; research profile; scholarly communication; Scopus; citation analysis; academic recognition; Cape Peninsula University of Technology; research metrics.

Introduction

Academic recognition commonly considers a combination of publication quality, scholarly influence, collaboration, and sustained research engagement. Bibliographic databases such as Scopus provide standardized indicators that assist institutions, reviewers, and award committees in evaluating research visibility while acknowledging that quantitative metrics represent only one component of scholarly assessment.[1][4]

Research Profile

Themba Ngobeni is affiliated with the Cape Peninsula University of Technology in South Africa. Publicly available indexing information identifies the researcher through Scopus Author ID 57219287291. The indexed profile reports three documents, two citations, and an h-index of one, reflecting an emerging publication record within the available indexed literature.[1]

Research Contributions

Research contributions are generally evaluated through originality, methodological rigor, dissemination, and scholarly influence. Public indexing demonstrates participation in peer-reviewed scholarly communication and provides a foundation for future research development. Citation-based indicators should be interpreted together with qualitative peer evaluation, institutional service, and broader disciplinary contributions.[1][4]

Publications

Available bibliographic records indicate that the author’s indexed publications contribute to the documented scholarly profile. Readers are encouraged to consult the official Scopus author record for the most current publication list and associated metadata. Persistent identifiers such as DOI records facilitate long-term discoverability and citation of scholarly outputs.[1][3]

Research Impact

Research impact extends beyond citation counts to include educational influence, professional practice, interdisciplinary collaboration, and societal relevance. Bibliometric indicators provide standardized comparative information but are most informative when interpreted alongside expert peer review and contextual evidence.[4]

Award Suitability

The documented scholarly profile demonstrates measurable participation in academic publishing and indexed research dissemination. Consideration for recognition within the Leadership Global Awards would ordinarily depend upon the complete evaluation criteria established by the award organizers, including qualitative assessment, innovation, leadership, professional achievements, and supporting evidence in addition to bibliometric indicators.[2][4]

Conclusion

This article provides a structured overview of publicly available information relating to Themba Ngobeni’s academic profile. The presentation is intended to serve as a concise reference summarizing institutional affiliation, research metrics, publication visibility, and relevant scholarly resources while maintaining a neutral encyclopedic perspective.[1]

References

  1. Elsevier. (2026). Scopus author details: Themba Ngobeni, Author ID 57219287291. Scopus.https://www.scopus.com/pages/authors/57219287291
  2. Leadership Global Awards. (2026). Leadership Global Awards.https://leadershipglobalawards.com/
  3. Conference proceedings. (2026). A generic framework for the implementation of a secure quantum teleportation infrastructure
    DOI:https://ieeexplore.ieee.org/document/9183891
  4. Conference proceedings. Towards a Secure Quantum Communication Implementation for OSI Layer 2 Devices
    DOI:https://ieeexplore.ieee.org/document/9183872

Dr. Barbara Wlodarczyk | Authentic Leadership | Best Researcher Award

Dr. Barbara Wlodarczyk | Authentic Leadership | Best Researcher Award

Department of Digestive Tract Diseases, Medical University of Lodz, Poland

Profile 

Google Scholar

Early Academic Pursuits 🎓

Barbara Wlodarczyk embarked on her academic journey at the Medical University of Lodz, Poland, where she earned her medical degree (2006–2011). Her time at the university not only honed her foundational medical knowledge but also fueled her interest in gastroenterology and pancreatic diseases. Continuing her academic pursuits, Barbara joined the Department of Digestive Tract Diseases as a Ph.D. student from 2013 to 2019, where her research delved into gastrointestinal disorders, particularly focusing on pancreatic diseases and metabolic pathways. She successfully defended her thesis and was awarded a Ph.D. in medical sciences in 2021, a testament to her dedication to advancing clinical understanding in gastroenterology.

Professional Endeavors 🩺

Barbara’s professional journey is deeply rooted in her commitment to gastroenterology. From 2014 to 2022, she specialized in gastroenterology at the Department of Digestive Tract Diseases in Lodz, refining her clinical skills in diagnosing and treating complex digestive disorders. Her expertise was formally recognized in November 2022, when she earned the title of Specialist in Gastroenterology. Barbara continued her career as an assistant at the same department, contributing to the field through clinical care and active participation in teaching and research.

Contributions and Research Focus 🔬

Barbara has made significant strides in understanding pancreatic adenocarcinoma (PDAC) and chronic pancreatitis (CP). Her research explores the relationship between insulin resistance, insulin-like growth factors (IGF-1), and other biomarkers like retinol-binding protein (RBP-4). Her work aims to enhance diagnostic precision for pancreatic diseases and develop novel biomarkers to differentiate between CP and PDAC.

Her scholarly contributions are evident in her active participation in numerous conferences:

  • At Digestive Disease Week 2016 in San Diego and 2017 in Chicago, Barbara presented groundbreaking findings on IGF-1 and RBP-4.
  • Her oral presentation at the Polish Pancreatic Club (2016) and the European Pancreatic Club (2018, Berlin) showcased her leadership in translating complex data into clinical insights.
  • She also co-organized and presented at events like Juvenes pro medicine (2010–2012), fostering interdisciplinary discussions on gastrointestinal endoscopy and malignancies.

Accolades and Recognition 🏆

Barbara’s research has been recognized both nationally and internationally. Her poster presentations at prestigious platforms, including the European Pancreatic Club Annual Meetings and the Polish Society of Gastroenterology Congress, underscore her dedication to advancing pancreatic disease diagnostics.

Moreover, her efforts have gained recognition from global organizations. She was a prominent presenter at international conferences like the Digestive Disease Week in the U.S. and the European Pancreatic Club meetings in Liverpool and Berlin, solidifying her reputation as a global contributor to gastroenterology research.

Impact and Influence 🌟

Barbara’s research is pioneering the use of biomarkers like IGF-1 and IGFBP-2 in differentiating pancreatic diseases. Her work holds promise for earlier and more accurate diagnosis of pancreatic adenocarcinoma, which could lead to improved survival rates and patient outcomes. Additionally, her ability to bridge clinical practice with research ensures that her findings are directly applicable to patient care.

As an educator, Barbara actively mentors young medical professionals, sharing her expertise in gastroenterology and research methodologies. Through her organizational roles, such as coordinating the gastroenterological course on premalignant and malignant gastrointestinal images, she has contributed to enhancing medical education and interdisciplinary collaboration.

Legacy and Future Contributions 🌏

Looking ahead, Barbara Wlodarczyk aims to deepen her research into innovative diagnostic tools and personalized treatment strategies for gastrointestinal diseases. Her ongoing focus on biomarkers in pancreatic adenocarcinoma sets the stage for advancements in early detection and therapeutic interventions.

Barbara’s influence extends beyond her academic and clinical achievements, inspiring a generation of young scientists and clinicians to pursue excellence in gastroenterology. Her work represents a vital contribution to the global effort to combat pancreatic diseases and improve digestive health, ensuring a lasting legacy in medical science. 🌟

📝Notable Publications

Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC)

Authors: B Wlodarczyk, A Gasiorowska, A Borkowska, E Malecka-Panas

Journal: Pancreatology

Year: 2017

Association of genetic variants affecting microRNAs and pancreatic cancer risk

Authors: Y Lu, C Corradi, M Gentiluomo, E López de Maturana, …

Journal: Frontiers in Genetics

Year: 2021

Serum levels of insulin-like growth factor 1 and insulin-like growth factor–binding protein 2 as a novel biomarker in the detection of pancreatic adenocarcinoma

Authors: B Wlodarczyk, A Borkowska, P Wlodarczyk, E Malecka-Panas, …

Journal: Journal of Clinical Gastroenterology

Year: 2020

The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer

Authors: D Campa, M Gentiluomo, A Stein, MN Aoki, M Oliverius, L Vodičková, …

Journal: Critical Reviews in Oncology/Hematology

Year: 2023

The role of insulin-like growth factor (IGF) axis in early diagnosis of pancreatic adenocarcinoma (PDAC)

Authors: B Wlodarczyk, A Gasiorowska, E Malecka-Panas

Journal: Journal of Clinical Gastroenterology

Year: 2018

Dr. Joshua Lin BWH | Authentic Leadership | Best Researcher Award

Dr. Joshua Lin BWH | Authentic Leadership | Best Researcher Award

BWH, United States

🔗 Professional Profiles

🌟 Summary:

Joshua K. Lin, Sc.D., is an Assistant Professor of Medicine at Harvard Medical School, specializing in Pharmacoepidemiology. He serves as an Attending Physician at Massachusetts General Hospital and an Investigator at Brigham and Women’s Hospital, focusing on optimal prescribing practices and healthcare data research.

📚 Education:

  • M.D., National Taiwan University, Taipei, Taiwan, 2006
  • M.P.H. in Epidemiology and Quantitative Methods, Harvard T.H. Chan School of Public Health, Boston, MA, 2009
  • Sc.D. in Pharmacoepidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 2017

👨‍⚕️ Professional Experience:

  • Current: Assistant Professor of Medicine, Harvard Medical School
  • Current: Attending Physician, Massachusetts General Hospital
  • Current: Investigator (Associate Epidemiologist), Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital
  • Previous: Instructor of Medicine, Harvard Medical School (2014-2019)
  • Previous: Resident in Medicine, Jacobi Medical Center, New York, NY (2010-2013)

🔬 Research Interests:

  • Comparative effectiveness of medications (📊)
  • Pharmacoepidemiology (💊)
  • Healthcare data analytics (📈)
  • Aging and geriatric pharmacotherapy (👴)

📝Notable Publications 

  • Author: Luis A García Rodríguez, Kueiyu Joshua Lin, Sonia Hernández-Díaz, Saga Johansson
  • Journal: Circulation
  • Year: 2011
  • Citations: 243
  • Author: Kueiyu Joshua Lin, Winson Y Cheung, Jennifer Yi‐Chun Lai, Edward L Giovannucci
  • Journal: International journal of cancer
  • Year: 2012
  • Citations: 194
  • Author: Yung-Cheng Su, Chien-Chih Chen, Yi-Kung Lee, Jae-Yeon Lee, Kueiyu Joshua Lin
  • Journal: European Journal of Anaesthesiology| EJA
  • Year: 2011
  • Citations: 191
  • Author: Kueiyu Joshua Lin, Sonia Hernández–Díaz, Luis A García Rodríguez
  • Journal: Gastroenterology
  • Year: 2011
  • Citations: 138
  • Author: Shirley V Wang, Sebastian Schneeweiss, Jessica M Franklin, Rishi J Desai, William Feldman, Elizabeth M Garry, Robert J Glynn, Kueiyu Joshua Lin, Julie Paik, Elisabetta Patorno, Samy Suissa, Elvira D’Andrea, Dureshahwar Jawaid, Hemin Lee, Ajinkya Pawar, Sushama Kattinakere Sreedhara, Helen Tesfaye, Lily G Bessette, Luke Zabotka, Su Been Lee, Nileesa Gautam, Cassie York, Heidi Zakoul, John Concato, David Martin, Dianne Paraoan, Kenneth Quinto, RCT-DUPLICATE Initiative
  • Journal: Jama
  • Year: 2023
  • Citations: 126

Prof Dr. ALEX IBHADON | Transformational Leadership | Best Researcher Award

Prof Dr. ALEX IBHADON | Transformational Leadership | Best Researcher Award

University of Hull, United Kingdom, United Kingdom

🔗 Professional Profiles

🎓 Education

  • PhD Chemistry, 1989, University of Birmingham, United Kingdom
  • MSc Chemistry, 1985, Ahmadu Bello University, Nigeria
  • BSc (Hons) Industrial Chemistry, 1981, University of Benin, Nigeria

👨‍🏫 Employment

  • 2019 – Present: Professor/Reader, University of Hull, United Kingdom
  • 2002-2019: Associate Professor, University of Hull, United Kingdom
  • 1996-2002: Assistant Professor, University of Hull, United Kingdom
  • 1991-1995: Postdoctoral Research Fellow, University of Newcastle, United Kingdom

🌟 Professional Qualifications

  • Fellow & Chartered Chemist, Royal Society of Chemistry, CChem FRSC, 2002, UK
  • Fellow, UK Higher Education Academy (FHEA), 2014, UK
  • Senior Fellow, UH Higher Education Academy (SFHEA), 2017, UK

📚 Teaching and Research in the UK

  • Internationally recognized for teaching excellence and curriculum design
  • Extensive experience in chemistry education at undergraduate and postgraduate levels
  • Significant contributions to teaching innovation and student engagement

🔬 Research Track Record

  • Focus on novel catalytic materials for sustainable chemical synthesis and renewable energy
  • Secured over £10.1M in research grants from EU, EPSRC, Royal Society, and BEIS
  • Pioneering work in decarbonization strategies in the UK’s Humber region
  • Patented inventions and spin-outs contributing to commercialization of research

🌍 Industry Engagement and Consultancy

  • Collaboration with over 350 industries in the Humberside region
  • Leading projects on resin formulation, hydrogen generation, and energy storage solutions
  • Key partnerships with organizations like EDF Energy and VUBA Chemical Innovations

🏆 Honors and Awards

  • Recognized for leadership in higher education and scientific research
  • Active involvement in national and international conferences and committees

This biography encapsulates Professor Alex Ibhadon’s illustrious career in academia, research, and industry, highlighting his profound impact on chemistry education, sustainable technology development, and industrial collaboration.

📖Publication Top Noted

 Paper Tittle: Heterogeneous photocatalysis: recent advances and applications

  • Authors: Alex Omo Ibhadon, Paul Fitzpatrick
  • Journal: Catalysts
  • Year: 2013
  • Citations:1533

 Paper Tittle: A review of the existing and alternative methods for greener nitrogen fixation

  • Authors: Nikolay Cherkasov, AO Ibhadon, P Fitzpatrick
  • Source: Chemical Engineering and Processing: Process Intensification
  • Year: 2015
  • Citations: 474

 Paper Tittle: Low temperature plasma-catalytic NOx synthesis in a packed DBD reactor: Effect of support materials and supported active metal oxides

  • Authors: BS Patil, Nikolay Cherkasov, J Lang, AO Ibhadon, Volker Hessel, Q Wang
  • Source: Applied Catalysis B: Environmental
  • Year: 2016
  • Citations: 186

 Paper Tittle: Solar light driven photocatalytic degradation of levofloxacin using TiO 2/carbon-dot nanocomposites

  • Authors: Shelja Sharma, Ahmad Umar, Surinder Kumar Mehta, Alex O Ibhadon, Sushil Kumar Kansal
  • Source: New Journal of Chemistry
  • Year: 2018
  • Citations: 108

Paper Tittle: Visible-light driven photocatalytic degradation of brilliant green dye based on cobalt tungstate (CoWO4) nanoparticles

  • Authors: Pankaj Taneja, Shelja Sharma, Ahmad Umar, Surinder Kumar Mehta, Alex O Ibhadon, Sushil Kumar Kansal
  • Source: Materials Chemistry and Physics
  • Year: 2018
  • Citations: 101